(Q35035816)

5 August 2017

1 reference

title

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes (English)

1 reference

5 August 2017

0 references

0 references

0 references

2

Billy R Martin

1 reference

5 August 2017

Jenny L Wiley

1

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Chemistry and Physics of Lipids

5 August 2017

published in

1 reference

5 August 2017

volume

121

1 reference

5 August 2017

issue

1-2

1 reference

5 August 2017

page(s)

57-63

1 reference

Pharmacological and behavioral evaluation of alkylated anandamide analogs

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

A review of central 5-HT receptors and their function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

The capsaicin receptor: a heat-activated ion channel in the pain pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Cannabinoid receptor localization in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Serotonin receptor and transporter ligands - current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Cannabinoid receptors and their ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Potent Anandamide Analogs: The Effect of Changing the Length and Branching of the End Pentyl Chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Synergistic interactions of endogenous opioids and cannabinoid systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Cannabis: discrimination of "internal bliss"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Discriminative stimulus effects of anandamide in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900146-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-3084(02)00146-9

1 reference

5 August 2017

1 reference